At this year’s summit, you’ll get unparalleled access to the latest pharmacovigilance insights, exclusive networking with Oracle leadership as well as customers and partners, and a deep dive into product roadmaps, innovation strategies, and more. The 2024 summit is an essential event for senior safety leadership, managers of safety, regulatory affairs professionals, and anyone committed to advancing drug safety through innovation in the pharmaceutical and biotech industries.
What to expect at Oracle Safety Innovation Summit EMEA
Latest safety insights : Dive into the latest advancements in pharmacovigilance, with a special focus on the EMEA region's unique challenges and opportunities, presented by industry leaders and Oracle experts.
Networking opportunities : Create valuable connections in pharmacovigilance with Oracle customers and partners, engage with Oracle leadership, and meet key figures in the safety community from across the region.
Leadership engagement : Speak directly with Oracle safety leadership in interactive sessions, gaining an in-depth look into the strategic direction of current and upcoming safety solutions.
Global perspectives, regional focus: Understand how regulatory trends specifically affect the EMEA region as well as on a global level, focusing on how to navigate safety operations within diverse regulatory environments.
Hear from your peers: Learn how your peers are innovating safety within their organizations and gain inspiration and practical guidance on how to transfer key learning experiences to your company.
Bruce Palsulich, VP of Safety, Oracle
Bruce will showcase how Oracle Health has become a multiplier in accelerating delivery of AI capabilities integrated into Oracle's safety solutions, as well as discuss how organizations can get the most value out of AI. Learn how you can apply AI to safety processes and see what's next on our innovation roadmap.
Yvonne Nanciu, PV Country Head, Bayer
Patient centricity continues to be a buzzword, but what is the reality? Yvonne Nanciu of Bayer will discuss what safety leaders can do to promote a patient-centric approach in pharmacovigilance. She will share practical examples and challenges, as well as future opportunities.
VP of Global Pharmacovigilance, Incyte Corp
Head of Safety Systems, BeiGene
Oracle
Bruce Palsulich, VP of Safety, Oracle
Bruce will showcase how Oracle Health has become a multiplier in accelerating delivery of AI capabilities integrated into Oracle's safety solutions, as well as discuss how organizations can get the most value out of AI. Learn how you can apply AI to safety processes and see what's next on our innovation roadmap.
Yvonne Nanciu, PV Country Head, Bayer
Patient centricity continues to be a buzzword, but what is the reality? Yvonne Nanciu of Bayer will discuss what safety leaders can do to promote a patient-centric approach in pharmacovigilance. She will share practical examples and challenges, as well as future opportunities.
Yvonne has more than 15 years of pharmacovigilance experience in various global and local positions, including roles at Johnson & Johnson in Germany and AbbVie in Switzerland. She now holds the position of Pharmacovigilance Country Head and QPPV Deputy at Bayer in Germany. Additionally, she is a lecturer for pharmacovigilance, and a passionate advocate for a patient-centric approach in the industry.